KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Non-cash Items: 2018-2019

Historic Non-cash Items for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Dec 2019 value amounting to $2.1 million.

  • Amneal Pharmaceuticals' Non-cash Items fell 20.30% to $2.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $2.1 million, marking a year-over-year decrease of 20.30%. This contributed to the annual value of $2.1 million for FY2019, which is 20.30% down from last year.
  • As of FY2019, Amneal Pharmaceuticals' Non-cash Items stood at $2.1 million, which was down 20.30% from $2.6 million recorded in FY2018.
  • In the past 5 years, Amneal Pharmaceuticals' Non-cash Items registered a high of $2.6 million during FY2018, and its lowest value of $2.1 million during FY2019.
  • In the last 2 years, Amneal Pharmaceuticals' Non-cash Items had a median value of $2.3 million in 2018 and averaged $2.3 million.
  • Data for Amneal Pharmaceuticals' Non-cash Items shows a maximum YoY fell of 20.30% (in 2019) over the last 5 years.
  • Over the past 2 years, Amneal Pharmaceuticals' Non-cash Items (Yearly) stood at $2.6 million in 2018, then fell by 20.30% to $2.1 million in 2019.